PurMinds NeuroPharma Announces PUR501 as Lead Candidate Novel Non-Hallucinogenic Neuroplastogen finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Toronto, Ontario and Boston, Massachusetts (Newsfile Corp. - May 23, 2024) - PurMinds NeuroPharma ("PurMinds" or the "Company"), a clinical-stage neuroscience company focused on advancing a robust pipeline
PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.